SLC25A20 and pancreatic neoplasm: ShRNA-mediated knockdown of SLC25A20 in the pancreatic cancer cell lines SU.86.86 reduced ATP production by 16-60% (Figure 3B, Figure S4A & C); however, there was no change in ATP production in pancreatic normal ductal epithelial cells (hTERT-HPNE) after SLC25A20 knockdown (Figure 3C, Figure S4B & D).